The development of CML-like disease in Icsbp−/− mice prompted us to examine whether Icsbp regulates the transition of LSK cells to more apoptotic LSK− cells during normal hematopoiesis. This evidence concerns the gene IRF8 and chronic myelogenous leukemia, BCR-ABL1 positive.